Randomized Trial of Antioxidant Vitamins to Prevent Acute Adverse Effects of Radiation Therapy in Head and Neck Cancer Patients
- 20 August 2005
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (24), 5805-5813
- https://doi.org/10.1200/jco.2005.05.514
Abstract
Purpose Many cancer patients take antioxidant vitamin supplements with the hope of improving the outcome of conventional therapies and of reducing the adverse effects of these treatments. A randomized trial was conducted to determine whether supplementation with antioxidant vitamins could reduce the occurrence and severity of acute adverse effects of radiation therapy and improve quality of life without compromising treatment efficacy. Patients and Methods We conducted a randomized, double-blind, placebo-controlled trial among 540 head and neck cancer patients treated with radiation therapy. Patients were randomly assigned into two arms. The supplementation with α-tocopherol (400 IU/d) and β-carotene (30 mg/d) or placebos was administered during radiation therapy and for 3 years thereafter. During the course of the trial, supplementation with β-carotene was discontinued because of ethical concerns. Results Patients randomly assigned in the supplement arm tended to have less severe acute adverse effects during radiation therapy (odds ratio [OR], 0.72; 95% CI, 0.52 to 1.02). The reduction was statistically significant when the supplementation combined α-tocopherol and β-carotene for adverse effects to the larynx (OR, 0.38; 95% CI, 0.21 to 0.71) and overall at any site (OR, 0.38; 95% CI, 0.20 to 0.74). Quality of life was not improved by the supplementation. The rate of local recurrence of the head and neck tumor tended to be higher in the supplement arm of the trial (hazard ratio, 1.37; 95% CI, 0.93 to 2.02). Conclusion Supplementation with high doses of α-tocopherol and β-carotene during radiation therapy could reduce the severity of treatment adverse effects. However, this trial suggests that use of high doses of antioxidants as adjuvant therapy might compromise radiation treatment efficacy.Keywords
This publication has 26 references indexed in Scilit:
- Assessment of quality of life (QOL) in MA.17, a randomized placebo-controlled trial of letrozole in postmenopausal women following five years of tamoxifenJournal of Clinical Oncology, 2004
- Protective effect of alpha‐tocopherol in head and neck cancer radiation‐induced mucositis: A double‐blind randomized trialHead & Neck, 2004
- Neuroprotective Effect of Vitamin E Supplementation in Patients Treated With Cisplatin ChemotherapyJournal of Clinical Oncology, 2003
- Advising Patients Who Seek Complementary and Alternative Medical Therapies for CancerAnnals of Internal Medicine, 2002
- Mega-dose vitamins and minerals in the treatment of non-metastatic breast cancer: an historical cohort study.Breast Cancer Research and Treatment, 2002
- Pros and cons of antioxidant use during radiation therapyCancer Treatment Reviews, 2002
- Nutrition during and after cancer treatment: a guide for informed choices by cancer survivors.CA: A Cancer Journal for Clinicians, 2001
- Prévention des seconds cancers primaires par supplémentation vitaminique chez les patients traités pour un cancer ORLBulletin du Cancer/Radiothérapie, 1996
- A double-blind, randomized, prospective trial to evaluate topical vitamin C solution for the prevention of radiation dermatitisInternational Journal of Radiation Oncology*Biology*Physics, 1993
- The modifying effect of beta-carotene on radiation and chemotherapy induced oral mucositisBritish Journal of Cancer, 1988